About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trials Prostate CancerTexas

Prostate Cancer Clinical Trials in Texas

Find 864 clinical trials for prostate cancer near Texas. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 241-260 of 864 trials

Active not recruitingM9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501)The purpose of this study is to evaluate the safety, tolerability, pharmacokinetic, pharmacodynamic profile of M9466 with and without tuvusertib or an ARPi and early signs of…NCT06421935·New York, New York and 19 others RecruitingAZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)The intention of the study is to demonstrate superiority of AZD2265 relative to standard of care treatments by assessment of radiographic progression-free survival (rPFS) and…NCT07611110·Dothan, Alabama and 150 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedHormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone MetastasesRATIONALE: Androgens can stimulate the growth of prostate cancer cells.NCT00081159·Orlando, Florida and 3 others

Active not recruitingEvaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate CancerThe main objective of this study is to evaluate the safety and tolerability of xaluritamig monotherapy in adult participants with high-risk biochemical recurrent (BCR)…NCT06555796·Minneapolis, Minnesota and 10 others

CompletedProstate Cancer Symptom Management for Low Literacy MenThis study will compare a newly-developed patient education program to help men with localized prostate cancer manage treatment-related side-effects versus usual care.NCT00983710·Houston, Texas

RecruitingProstate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL StudyThis study investigates ways to detect prostate cancer earlier in people at genetic risk for disease that forms, grows, or spreads quickly (aggressive).NCT04472338·Duarte, California and 7 others

Active not recruitingA Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPCThe purpose of the study is to determine if the intermittent use of androgen-deprivation therapy (ADT) in participants with metastatic castrate-sensitive prostate cancer (mCSPC)…NCT05884398·Homewood, Alabama and 92 others

TerminatedExternal Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate CancerPrimary Objective: * To assess the possible improvement in prostate specific antigen (PSA) outcome of short course androgen suppression therapy in conjunction with…NCT00388804·Houston, Texas

WithdrawnAntineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate CancerRATIONALE: Antineoplastons are naturally occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells.NCT00003517·Houston, Texas

Active not recruitingSpaceIT Hydrogel System for Perirectal SpacingTo evaluate the safety and effectiveness of the SpaceIT™ Hydrogel System in patients undergoing External Beam Radiotherapy (EBRT) for the treatment of prostate cancer.NCT06451614·Laguna Hills, California and 25 others

Active not recruitingA Study of Evofosfamide in Combination With Zalifrelimab and BalstilimabThe purpose of this Phase 1/2 study is to test the overall safety, tolerability, and effectiveness of the combination investigational drugs evofosfamide, zalifrelimab, and…NCT06782555·Houston, Texas

TerminatedSafety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate CancerThe purpose of this study is to assess the relative efficacy and toxicity of combination therapy of GM-CSF, Thalidomide plus Docetaxel in patients with prostate cancer with a…NCT00450008·Houston, Texas

Active not recruitingStudy of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)This study will assess the efficacy and safety of capivasertib plus docetaxel versus placebo plus docetaxel in participants with metastatic castration resistant prostate cancer…NCT05348577·Yuma, Arizona and 216 others

Active not recruitingA Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate CancerThe purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate cancer.NCT01946204·Birmingham, Alabama and 378 others

CompletedCholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate CancerThis randomized phase II trial studies cholecalciferol and genistein compared to placebo in treating patients with early stage prostate cancer.NCT01325311·Birmingham, Alabama and 10 others

RecruitingA Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate CancerThe primary purpose of this study is to evaluate the safety, tolerability, and efficacy of SYNC-T Therapy SV-102 and to identify the maximum tolerated dose (MTD) and/or selected…NCT06533644·Phoenix, Arizona and 22 others

Active not recruitingStudy Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate CancerThe main objective of the trial is to evaluate the safety and tolerability of xaluritamig in combination with darolutamide or abiraterone.NCT07140900·San Francisco, California and 15 others

RecruitingA Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid TumorsThe goal of this clinical trial is to evaluate whether TJ101, an investigational antibody-drug conjugate (ADC), can safely and effectively treat patients with advanced solid…NCT07181473·Orlando, Florida and 6 others

Active not recruitingAn Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)This Phase II study aims to evaluate efficacy and safety of the combination of JSB462 (also known as luxdegalutamide) at 100 mg and 300 mg once a day (QD) doses + abiraterone…NCT06991556·La Jolla, California and 63 others

RecruitingSample Collection for Ongoing Research and Product Evaluation StudyThe SCORE study is a prospective, multi-site clinical trial designed to collect blood and tissue samples, along with relevant clinical data, from participants diagnosed with…NCT07318051·Austin, Texas

PreviousPage 13 of 44Next

Other Conditions in Texas

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma